713 related articles for article (PubMed ID: 19653045)
1. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
2. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.
Damle S; Teal CB; Lenert JJ; Marshall EC; Pan Q; McSwain AP
Ann Surg Oncol; 2011 May; 18(5):1356-63. PubMed ID: 21125335
[TBL] [Abstract][Full Text] [Related]
3. Perceptions of contralateral breast cancer: an overestimation of risk.
Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
[TBL] [Abstract][Full Text] [Related]
4. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
[TBL] [Abstract][Full Text] [Related]
5. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.
Yao K; Stewart AK; Winchester DJ; Winchester DP
Ann Surg Oncol; 2010 Oct; 17(10):2554-62. PubMed ID: 20461470
[TBL] [Abstract][Full Text] [Related]
6. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
[TBL] [Abstract][Full Text] [Related]
7. Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer.
Stucky CC; Gray RJ; Wasif N; Dueck AC; Pockaj BA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():330-7. PubMed ID: 20853055
[TBL] [Abstract][Full Text] [Related]
8. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients.
McGuire KP; Santillan AA; Kaur P; Meade T; Parbhoo J; Mathias M; Shamehdi C; Davis M; Ramos D; Cox CE
Ann Surg Oncol; 2009 Oct; 16(10):2682-90. PubMed ID: 19653046
[TBL] [Abstract][Full Text] [Related]
9. The influence of preoperative MRI on breast cancer treatment.
Miller BT; Abbott AM; Tuttle TM
Ann Surg Oncol; 2012 Feb; 19(2):536-40. PubMed ID: 21751044
[TBL] [Abstract][Full Text] [Related]
10. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
[TBL] [Abstract][Full Text] [Related]
11. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
[TBL] [Abstract][Full Text] [Related]
12. Contralateral prophylactic mastectomy.
Rai SS; Mahabir RC; Roberts JW; Song J; Hamid KS; White RR
Ann Plast Surg; 2011 Sep; 67(3):215-9. PubMed ID: 21508813
[TBL] [Abstract][Full Text] [Related]
13. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.
Jones NB; Wilson J; Kotur L; Stephens J; Farrar WB; Agnese DM
Ann Surg Oncol; 2009 Oct; 16(10):2691-6. PubMed ID: 19506956
[TBL] [Abstract][Full Text] [Related]
14. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.
Barry PN; Johnson RR; Harkenrider MM; Freeman AB; Kruse B; Wilson MR; Pan J; Dragun AE
Am J Med Sci; 2012 Dec; 344(6):452-6. PubMed ID: 22395715
[TBL] [Abstract][Full Text] [Related]
15. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
16. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy.
Hoskin TL; Hieken TJ; Degnim AC; Jakub JW; Jacobson SR; Boughey JC
Surgery; 2016 Apr; 159(4):1199-209. PubMed ID: 26704783
[TBL] [Abstract][Full Text] [Related]
17. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
[TBL] [Abstract][Full Text] [Related]
18. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
Goldflam K; Hunt KK; Gershenwald JE; Singletary SE; Mirza N; Kuerer HM; Babiera GV; Ames FC; Ross MI; Feig BW; Sahin AA; Arun B; Meric-Bernstam F
Cancer; 2004 Nov; 101(9):1977-86. PubMed ID: 15389473
[TBL] [Abstract][Full Text] [Related]
19. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
[TBL] [Abstract][Full Text] [Related]
20. Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery.
Zografos GC; Roukos DH
Ann Surg Oncol; 2010 Mar; 17(3):939; author reply 940. PubMed ID: 19937131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
